Carboplatin
Found 7 free book(s)
DRUG NAME: Carboplatin - BC Cancer
www.bccancer.bc.caCarboplatin Myelosuppression is the dose-limiting toxicity, usually manifested as thrombocytopenia and less commonly as leukopenia, neutropenia and anemia. Risk factors include prior cytotoxic therapy (especially cisplatin), poor performance status, old age, impaired renal function and concurrent myelosuppressive therapy.
Protocol: Carboplatin/Paclitaxel - Mid-Western Cancer Centre
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 57 Protocol: Carboplatin Indications: Ovarian Cancer – Advanced, Recurrent
BC Cancer Protocol Summary for Primary Treatment of No ...
www.bccancer.bc.caBC Cancer Protocol Summary for Primary Treatment of No Visible Residual (Moderate-High Risk) Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal CancerUsing CARBOplatin and
Protocol: Carboplatin/Gemcitabine - Mid-Western Cancer …
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 2 Protocol: Cisplatin/Gemcitabine Indications: Lung Cancer (non-small cell) – Adjuvant, Neoadjuvant
Carboplatin / Etoposide (IV D1; PO D2,D3) in Metastatic or ...
www.londoncanceralliance.nhs.ukFebrile neutropenia is diagnosed, Consider Etoposide 75% dose and Carboplatin 100% dose . Renal Impairment: Carboplatin: Contraindicated if CrCl < 20ml/min
CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION …
www.mhra.gov.ukMHRA-UKPAR – Carboplatin 10 mg/ml Concentrate for Solution for Infusion PL 08137/0150-2 -6 - Pharmaceutical Development The aim of the pharmaceutical development programme was to produce a …
Keytruda® (pembrolizumab) Injectable Medication ...
www.aetna.comGR-69035 (4-18) Keytruda ® (pembrolizumab) Injectable Medication Precertification Request Page 2 of 5 (All fields must be completed and legible for Precertification Review.)
Similar queries
DRUG NAME: Carboplatin, Carboplatin, Protocol: Carboplatin/Paclitaxel, Protocol: Carboplatin/Gemcitabine, Carboplatin / Etoposide IV D1; PO, CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION, Carboplatin 10 mg/ml Concentrate for Solution for Infusion, Pembrolizumab) Injectable Medication Precertification Request